Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section
Home Videos Research Press Release Q&A Discussion
Discussion Parent
Threads Posts
Piper Jaffray today maintained an Overweight rating on MannKind
Mannkind
over 11 years ago
2
Re: Piper Jaffray today maintained an Overweight rating on MannKind
Mannkind
over 11 years ago
0
in response to bospenc's message

Takeda may be another potential partner. They have recently lost market exclusivity for Actos and revenues fell down quite a bit. They have experience in diabetes sales & marketing.

Oncostat

Please login to post a reply
oncostat
City
Chicago
Rank
Mail Room
Activity Points
100
Rating
Your Rating
Please Log In to Vote
Date Joined
06/16/2012
Social Links
Private Message
Mannkind
Stock Quotes
Symbol
MNKD
Exchange
NAZ
Shares
Industry
Technology & Medical
Website
Create a Post
Follow Hub
Disclaimer